Status:
WITHDRAWN
Celecoxib Treatment for Lung Cancer
Lead Sponsor:
US Department of Veterans Affairs
Collaborating Sponsors:
University of California, Los Angeles
City of Hope Medical Center
Conditions:
Non-Small-Cell Lung Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This proposal evaluates cyclooxygenase 2 (COX-2) inhibition as a means to decrease T regulatory cell activities and thus augment immune responses against lung cancer. The broad goal focuses on underst...
Eligibility Criteria
Inclusion
- Pathologically confirmed and surgically resectable non small cell lung cancer and subjects must be ineligible for or refuse, neoadjuvant therapy
Exclusion
- Hypersensitivity to celecoxib or NSAIDs, previous history of GI bleeding or ulceration, chronic or concurrent use of steroids and renal insufficiency
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00108186
Start Date
October 1 2004
End Date
June 1 2011
Last Update
October 29 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Greater Los Angeles Healthcare System, West LA
West Los Angeles, California, United States, 90073